Overview

Assess Fibrin in Brains With AD/ADRD

Status:
Recruiting

Trial end date:
2022-09-28

Target enrollment:

Participant gender:

Summary

The goal of this project is to quantify brain fibrin content using 64Cu-FBP8-PET in the brains of subjects ranging from cognitively normal to clinically diagnosed with ADRD to evaluate potential regional differences.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Massachusetts General Hospital

Collaborator:

National Heart, Lung, and Blood Institute (NHLBI)